|
American Conference for the Treatment of HIV (ACTHIV)
|
Meeting/ Workshop
|
CDC
|
OD/DPCPSI/OAR
|
The American Conference for the Treatment of HIV (ACTHIV) is a state-of-the-science conference for frontline health care professionals, in scientific collaboration with multiple Federal and independent agencies. The conference is designed for all frontline clinicians providing HIV care for various population groups.
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NINDS, NCATS, NCI, NIAAA, NIDA
|
The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health.
|
|
Analysis of Mycotoxins in Dust Samples From a Water Damaged Building
|
Research Initiative
|
CDC
|
NIEHS
|
These studies are developing methods to quantitate the levels of fungal products in dust samples from water damaged buildings so that biomarkers of effect, such as fungal specific antibodies, can be correlated with biomarkers of exposure.
|
|
Anti-Infective Drugs Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval.
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC, FDA
|
NICHD
|
This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by various pharmaceutical companies and has a committee of external experts and government staff from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA).
|
|
Armed Forces Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIAID
|
The National Institute of Allergy and Infectious Diseases (NIAID) participates on the Armed Forces Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team to collaborate and provide subject matter expertise, advice, and guidance on establishing a quailty assurance program at AFRRI for GLP compliance.
|
|
Assessing Safety of Cell Substrates and Vaccine Components
|
Research Initiative
|
FDA
|
NIAID
|
Production of many new vaccines requires the use of novel cell substrates. It is critical that these new cell substrates be well characterized and undergo rigorous safety testing prior to their use in manufacturing vaccines for human use. This IAA will examine the potential infectivity acquired by various cell lines after exposure to prions.
|
|
Asthma Supplement to the National Ambulatory Medical Care Survey (NAMCS)
|
Health Survey
|
CDC
|
NHLBI, NIAID, NICHD, NIEHS
|
The National Ambulatory Medical Care Survey (NAMCS) Asthma Supplement is a national survey of physicians opinions about and use of the National Asthma Education and Prevention Program (NAEPP) Guidelines for the Diagnosis and Management of Asthma. The National Institutes of Health and the National Center for Health Statistics collaborate on this activity.
|
|
Auditory (Hearing) Screening Supplement for Early Childhood Longitudinal Study
|
Health Survey
|
CDC
|
NIDCD
|
The objective of this Inter-Agency Agreement is to implement a hearing examination protocol in the Early Childhood Longitudinal Study of the Kindergarten Class of 2010–11. This is a large (n=20,000), nationally representative school-based exam and interview survey sponsored by the National Center for Education Statistics (NCES), U.S. Department of Education. The last NCES longitudinal cohort study of school age children began with the 1998 Kindergarten Class. In this earlier cohort, there were no hearing exams (nor vision exams) and the number of young children with hearing loss (reported by parents or teachers) shrank considerably after the initial enrollment of Kindergarteners. In the U.S., the last comprehensive national study of children with hearing exam measures was the 1963–1965 National Health Examination Survey (NHANES predecessor) for children aged 6 to 11 years. A randomly selected sub-sample of about 4500 children were identified for more frequent follow-up and these children have also been selected for the hearing examination; they are also included in a “selected” (protected) subsample for more intensive tracking in follow-up waves of the survey. Children in the selected subsample will be tracked to new schools when possible if they are later enrolled in (moved to) a school that was not in the original school sample, e.g., when families relocate. In addition to hearing, the ECLS-K:2010-11 will track several other outcome measures (e.g., general health, social and physical development, achievement scores, and parental and teacher-reported communication problems) associated with educational performance. Hearing will be tested when the children are examined with achievement testing in the school setting. NCES has awarded a contract to WESTAT to conduct the field operations, including selection of sample schools, data collection, and preparation of user-friendly research data files. The contractor will obtain longitudinal measures of hearing sensitivity and middle ear function of Kindergartners during the fall of Second grade, spring of Third grade, and spring of Fifth grade. Hearing thresholds will be recorded from each ear separately. In addition, the contractor will obtain tympanometric traces to assess middle ear function and, also, wideband reflectometry beginning in the spring of Third grade to improve classification of sensorineural versus conductive hearing loss.
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCCAM, CSR, FIC, NCATS, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
This group provides a forum for the coordination of research efforts in autoimmunity and autoimmune diseases among various stakeholders including the NIH, other federal agencies such as the FDA and the CDC, and private organizations with an interest in autoimmune diseases. The ADCC meets twice yearly to discuss a broad range of basic, preclinical and clinical endeavors.
|